======= BCL9 =======
== Gene Information ==
* **Official Symbol**: BCL9
* **Official Name**: BCL9 transcription coactivator
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=607|607]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O00512|O00512]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=BCL9&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BCL9|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602597|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity (By similarity). {ECO:0000250, ECO:0000269|PubMed:11955446}.
|BCL9|
|myotube differentiation involved in skeletal muscle regeneration|
|beta-catenin-TCF complex|
|beta-catenin-TCF complex assembly|
|skeletal muscle tissue regeneration|
|skeletal muscle cell differentiation|
|myotube differentiation|
|tissue regeneration|
|cis-Golgi network|
|somatic stem cell population maintenance|
|beta-catenin binding|
|canonical Wnt signaling pathway|
|regulation of transforming growth factor beta receptor signaling pathway|
|regulation of cellular response to transforming growth factor beta stimulus|
|skeletal muscle tissue development|
|skeletal muscle organ development|
|stem cell population maintenance|
|maintenance of cell number|
|regeneration|
|striated muscle cell differentiation|
|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|muscle cell differentiation|
|regulation of cellular response to growth factor stimulus|
|transcription coactivator activity|
|striated muscle tissue development|
|muscle organ development|
|muscle tissue development|
|cell-cell signaling by wnt|
|Wnt signaling pathway|
|developmental growth|
|growth|
|cell surface receptor signaling pathway involved in cell-cell signaling|
|muscle structure development|
|wound healing|
|response to wounding|
|cell-cell signaling|
|positive regulation of transcription by RNA polymerase II|
|positive regulation of transcription, DNA-templated|
|protein-containing complex assembly|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|tissue development|
|protein-containing complex subunit organization|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|1.81|
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.22|
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|3.62|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4877
* **Expression level (log2 read counts)**: 5.24
{{:chemogenomics:nalm6 dist.png?nolink |}}